33RD ANNUAL GENERAL MEETING NOTICE

B BCRHL Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M. P.) INDIA Tel.: (0731) 2517677 | E-mail: beryldrugs25@yahoo.com | CIN: L02423MP1993PLC007840 Date: 03.09.2026 DCS-Listing The Bombay Stock Exchange Limited, Phiroze Jeeleebhoy Towers, Dalal Street, ’ Mumbai- 400001 Sub: Notice of 33" Annual Gene-ral Meeting Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015, we are enclosing the Notice of the 33™ Annual General Meeting of the Members of the Company to be held on Tuesday, the 29" day of September, 2026. This will also be placed on our website www.beryldrugs.com. This is for information and records. Yours Sincerely For Beryl Drugs Limited, Chairman& Dire DIN: 00090172 33° Annual Report BERYL brUGS LTD. NOTICE 33" ANNUAL GENERAL MEETING NOTICE is hereby given that the Thirty- Third (33rd) Annual General Meeting of Members of BERYL DRUGS LIMITED will be held on Tuesday, 29th September, 2026 at 11:00 A.M. at Kanchan Palace, Community Hall, Nipania Ring Road Indore (M.P.) to transatchte following businesses: ORDINARY BUSINESS: 1. Toreceive, consider and adtohe Apuditted Standalone Financial Statements of the Company for the Financial Year ended 31st March 2026, together with the reports of the Board of Directors and Auditors thereon, and in this regard, to consider and if thought fit, to pass, with orwithout modification (s) the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon laid before this meeting, be and are hereby considered and adopted.” Tore-appoint Mr. Sudhir Sethi (DIN: 00090172), who retires by rotation as a director and in this regard, to consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, Mr. Sudhir Sethi (DIN: 00090172), who retires by rotation at this meeting be and is hereby re-appointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS: 3. Approval for increase in the limit of material related party transactions with m/s. Aminova infusions pvt. Ltd. To consider and, if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the applicable provisions of the Companies Act, 2013 (“Act”) read with the applicable Rules made thereunder, including Section 188 and other applicable provisions of the Act, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), including Regulation 23 and other applicable provisions thereof, as amended from time to time, the Securities and Exchange Board of India circulars/guidelines applicable to Related Party Transactions, the Company's Policy on Materiality of Related Party Transactions and on dealing with Related Party Transactions, and all other applicable laws, rules, regulations, circulars and guidelines, as amended, supplemented or re- enacted from time to time, and pursuantto the approval and recommendation of the Audit Committee and the Board of Directors of the Company, consent of the Members of the Company be and is hereby accorded to revise the aggregate maximum value of the material related party transactions with M/s. Aminova Infusions Pvt Ltd. (“Aminova”) from ¥5.00 crore to ¥8.00 crore, as approved by the Members pursuant to the earlier resolution passed at the Extra Ordinary General Meeting (EOGM) held on 11th May, 2026, during the unexpired period of the existing tenure of such approval. “RESOLVED FURTHER THAT except for the aforesaid increase in the aggregate maximum monetary limit from ¥5.00 crore to Z8.00 crore, all other terms and conditions, nature of transactions, tenure and other parameters of the earlier approval shall remain unchanged and continue to remain in force for the originally approved period of two years.” 33° Annual Report BERYL brUGS LTD. “RESOLVED FURTHER THAT the revised aggregate maximum limit of 8.00 crore shall be the overall ceiling for the transactions covered under the existing approval during the originally approved two-year tenure, and the same shall not be construed as an additional Z8.00 crore limit over and above the transactions already undertaken pursuantto the earlier approval.” “RESOLVED FURTHER THAT all transactions with Aminova pursuant to this approval shall continue to be undertaken in the ordinary course of business and on an arm's length basis and shall remain subject to the applicable provisions of the Act, SEBI Listing Regulations, the Company's Related Party Transactions Policy and such other approvals, consents, permissions and sanctions asmay be necessary.” “RESOLVED FURTHER THAT the Audit Committee shall review/monitor the Related Party Transactions in accordance with applicable law and the Company's Related Party Transactions Policy and any subsequent material modification, wherever applicable, shall be dealt with in accordance with the applicable provisions of the SEBI Listing Regulations and the Act.” “RESOLVED FURTHER THAT pursuant to Regulation 23(4) of the SEBI Listing Regulations, no related party of the Company shall vote to approve this resolution, whether or not such related party isarelated parttyo the particular transaction.” RESOLVED FURTHER THAT the Board of Directors of the Company (hereinafter referred to as the “Board”, which term shall include any Committee thereof duly constituted by the Board) be and is hereby authorised to do all such acts, deeds, matters and things and to execute all such agreements, documents and writings as may be necessary, proper, expedient or incidental for giving effect to this resolution, including delegation of all or any of the powers conferred herein, and to settle any questions, difficulties ordoubtsthat mayarise in this regard. Registered Office: By Order of the Board 29, Neer Nagar, for Beryl Drugs Limited Mayank Water Park Road Indore-452016 Sd/- Sanjay Sethi Dated: 2™ September, 2026 Managing Director (DIN: 00090277) 33° Annual Report BERYL brUGS LTD. NOTES AMEMBERENTITLED TOATTENDAND VOTE IS ENTITLED TOAPPOINTAPTORAOTTXENYD AND VOTE ONAPOLL INSTEAD OF HIMSELF AND THE PROXY NEED NOT BE AMEMBER. A BLANK FORM OF PROXY IS ATTACHED HEREWITH AND IF INTENDED TO BE USED, IT SHOULD BE RETURNED DULY COMPLETAENDD SIGNATE TDHE REGISTERED OFFICE OF THE COMPANY NOT LESS THAN FORTY-EIGHT HOURS BEFORE THE SCHEDULED TIME OF THE COMMEOF 3N0THACNNUEAL GMENEREAL NMEETTING. A PERSON CAN ACT AS APROXY ON BEHALF OF MEMBERS NOT EXCEEDING FIFTY AND HOLDING IN THE AGGREGATE NOT MORE THAN TEN PERCENT OF THE TOTAL SHARE CAPITAL OF THE COMPANY CARRYING VOTING RIGHTS. AMEMBER HOLDING MORE THAN TEN PERCENT OF THE TOTAL SHARE CAPITAL OF THE COMPANY CARRYING VOTING RIGHTS MAY APPOA ISINNGTLE PERSOANS PROXY AND SUCH PERSON SHALL NOT ACT AS APROXY FORANY OTHER PERSON ORAMEMBER. The register of members and share transfer books of the Company shall remain closed from 23rd September, 2026 to 29th September, 2026 (both days inclusive). Members are requested to intimate immediately any change in their addresses at the registered office ofthe Company. Shareholders desiring any information on the Accounts at the Annual General Meeting are requested to intimate the Company at least 7 days in advance so, as to enable the Company to keep the information ready. Shareholders are requested to bring their copy of Annual Report to the meeting along with the attendance slip. The members holding shares inidentical order of names in more than one folio are requested to write to the Share transfer agent of the Company to consolidate their holding in one folio. Members are requested to quote their F [Showing first 8,000 characters — download PDF for full document]